After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Crinetics Pharmaceuticals Inc is $3.26B. A total of 1.77 million shares were traded on the day, compared to an average of 833.35K shares.
In the most recent transaction, DANA PIZZUTI bought 5,000 shares of CRNX for 30.99 per share on Sep 02 ’25. In a previous transaction on Aug 22 ’25, Pizzuti Dana sold 30,000 shares at 30.43 per share. CRNX shares that Chief Med and Dev Officer owns now total 66,270.
Among the insiders who bought shares, DANA PIZZUTI acquired of 30,000 shares on Aug 22 ’25 at a per-share price of $29.40. In another insider transaction, Pizzuti Dana sold 6,492 shares at $29.18 per share on Aug 20 ’25. Company shares held by the Chief Med and Dev Officer now total 66,270.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, CRNX has a high of $62.53 and a low of $24.10.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CRNX’s latest balance sheet shows that the firm has $333.71M in Cash & Short Term Investments as of fiscal 2021. There were $3.07M in debt and $15.99M in liabilities at the time. Its Book Value Per Share was $12.45, while its Total Shareholder’s Equity was $331.94M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRNX is Buy with a score of 4.68.
